Skip to main content

letter

. 1990 May 5;300(6733):1195. doi: 10.1136/bmj.300.6733.1195-b

Lipid lowering drugs.

T S Bocanegra, J A Tobert

PMCID: PMC1662889 PMID: 2112035

1195

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Germershausen J. I., Hunt V. M., Bostedor R. G., Bailey P. J., Karkas J. D., Alberts A. W. Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo. Biochem Biophys Res Commun. 1989 Feb 15;158(3):667–675. doi: 10.1016/0006-291x(89)92773-3. [DOI] [PubMed] [Google Scholar]
Mosley S. T., Kalinowski S. S., Schafer B. L., Tanaka R. D. Tissue-selective acute effects of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase on cholesterol biosynthesis in lens. J Lipid Res. 1989 Sep;30(9):1411–1420. [PubMed] [Google Scholar]
O'Connor P., Feely J., Shepherd J. Lipid lowering drugs. BMJ. 1990 Mar 10;300(6725):667–672. doi: 10.1136/bmj.300.6725.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
Tsujita Y., Kuroda M., Shimada Y., Tanzawa K., Arai M., Kaneko I., Tanaka M., Masuda H., Tarumi C., Watanabe Y. CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim Biophys Acta. 1986 Jun 11;877(1):50–60. doi: 10.1016/0005-2760(86)90117-7. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES